Abstract
Thirty-two patients with irritable bowel syndrome were randomly assigned to one of three treatment conditions: cognitive therapy in small groups of 3 to 5 individuals; cognitive therapy in an individual format; or an 8-week symptom-monitoring waitlist control. Treatment consisted of 10 sessions. Pre- to posttreatment evaluations showed significantly greater gastrointestinal symptom reduction on a composite measure for the treated subjects than for the symptom-monitoring condition (p = .01); the group cognitive treatment and individual cognitive treatment conditions did not significantly differ. At posttreatment, 64% of the group cognitive treatment condition and 55% of the individual cognitive treatment condition showed clinically significant improvement (at least a 50% reduction in the composite measure) as compared to 10% of the monitoring group. Treatment gains were maintained for those who responded (12 of 22 treated subjects) to a 3-month follow-up study.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
